Second lethal events associated with treatment for Hodgkin's disease: A review of 2980 patients treated in a single Mexican institute

Leukemia and Lymphoma

Volumn 39, Issue 3-4, 2000, Pages 311-319

  Aviles A ^a   Neri, N ^a   Cuadra, I ^a   Alvarado, I ^a   Cleto, S ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Hodgkin's disease; Second events; Therapy associated; Therapy for Hodgkin's disease

Indexed keywords

ALKYLATING AGENT; ALPHA2B INTERFERON; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; MECHLORETAMINE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LETHALITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; STATISTICAL ANALYSIS;

EID: 0034489571     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009065830     Document Type: Article

References (27)

1. The consequences of the chemotherapy of Hodgkin's disease
2. Hodgkin's disease: Long term effects of therapy
3. Leukemia following Hodgkin's disease
4. Second solid tumors and leukemia after treatment for Hodgkin's disease. An analysis of 1121 patients from a single institution
5. Risk of subsequent malignant neoplasms among 1041 Hodgkin's disease patients diagnosed in childhood and adolescents
6. Second malignancies after treatment of Hodgkin's disease. The influence of treatment, follow-time and age
7. Incidence of second cancers in patients treated for Hodgkin's disease
8. Second primary cancer following Hodgkin's disease
9. Leukemia complicating treatment for Hodgkin's disease
10. Outcome of clinical congestive heart failure induced by anthracycline chemotherapy
11. Pericarditis and myocardial infarctations after Hodgkin's disease therapy
12. Cardiac function, perfusion and morbidity in irradiated long term survivors of Hodgkin's disease
13. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early stage Hodgkin's disease
14. Late effects of treatment for early-stage Hodgkin's disease
15. Cardiopulmonary sequelae after treatment for Hodgkin's disease. Increased risk in females?
16. Cardiac disease following treatment of Hodgkin's disease in children and adolescents
17. Increase mortality after successful treatment for Hodgkin's disease
18. Hodgkin's lymphoma. II Treatment and delayed mortality
19. Late cardiac toxicity of doxorubicin, epirubicin and mitoxantrone therapy for Hodgkin's disease in adults
20. Statistical methods in cancer research
21. Non-parametric estimation from incomplete observations
22. Desing and analysis of randomized clinical trials required prolonged observation of each patient. II: Analysis and examples
23. Statistical aspects of the analysis of data from retrospective studies of disease
24. Late evaluation of cardiotoxicity in patients with malignant lymphoma treated with intensive chemotherapy regimens
25. Second cancer among long term survivors from Hodgkin's disease
26. Hodgkin's disease and acute leukemia. Is it a true association?